Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. - Wikidata - wikimedia - TriplyDB

Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.

Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.

http://www.wikidata.org/entity/Q38075417

about

ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies Reducing myocardial infarct size: challenges and future opportunities The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning Remote ischemic conditioning: from experimental observation to clinical application: report from the 8th Biennial Hatter Cardiovascular Institute Workshop Role of the MPTP in conditioning the heart - translatability and mechanism Ischaemic postconditioning: cardiac protection after the event Ischaemic conditioning: pitfalls on the path to clinical translation Postconditioning signalling in the heart: mechanisms and translatability A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model Cardioprotection: Where to from here?Remote ischaemic conditioning reduces infarct size in animal in vivo models of ischaemia-reperfusion injury: a systematic review and meta-analysis Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance.Activation of complement factor B contributes to murine and human myocardial ischemia/reperfusion injury.Adjuvant cardioprotection in cardiac surgery: update.A randomized pilot trial of remote ischemic preconditioning in heart failure with reduced ejection fraction.Did a classic preconditioning study provide a clue to the identity of the mitochondrial permeability transition pore?Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial.Life without oxygen: gene regulatory responses of the crucian carp (Carassius carassius) heart subjected to chronic anoxia Ischemic conditioning: the challenge of protecting the diabetic heart.Remote ischemic conditioning.ERICCA and RIPHeart: two nails in the coffin for cardioprotection by remote ischemic conditioning? Probably not!Obligatory role of intraluminal O2- in acute endothelin-1 and angiotensin II signaling to mediate endothelial dysfunction and MAPK activation in guinea-pig hearts.Reperfusion therapy with low-dose insulin or insulin-like growth factor 2; myocardial function and infarct size in a porcine model of ischaemia and reperfusion.Decreased myocardial injury and improved contractility after administration of a peptide derived against the alpha-interacting domain of the L-type calcium channel The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs On-line visualization of ischemic burden during repetitive ischemia/reperfusion.Redox signalling and cardioprotection: translatability and mechanism Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection?Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway.Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury.A Role for Photobiomodulation in the Prevention of Myocardial Ischemic Reperfusion Injury: A Systematic Review and Potential Molecular Mechanisms.Ilexsaponin A attenuates ischemia-reperfusion-induced myocardial injury through anti-apoptotic pathway.Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedside Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer.A Clinical Experimental Model to Evaluate Analgesic Effect of Remote Ischemic Preconditioning in Acute Postoperative Pain.At the crossroads from bench to bedside: luteolin is a promising pharmacological agent against myocardial ischemia reperfusion injury.Therapeutic potential of midkine in cardiovascular disease.Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice.In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvascu Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations.

P2860

Q24289195-E91B0B12-C5A2-4124-BEFA-16ADD6151CAF Q26775395-F59D14C6-3333-45E7-B6B8-A792920F84FC Q26825733-9EF0CE94-8636-4BFC-92DE-9B634800CE91 Q26828968-C9570769-27A4-46FC-A21E-70B5E92FA8E4 Q26830560-D16FA378-EE9A-4835-8967-3BAF8268AE2D Q26853129-BD09922F-9295-403D-A0F2-BCC4829CB213 Q27000466-4F1623EB-7F86-4D37-B698-851E143BF173 Q27021021-07506167-FEE3-4C30-8C8D-9C26F4876C18 Q28546468-D06C888E-C047-47F2-AF3B-F1E6E926FD1F Q30244797-107362DC-4CA7-4B18-AA4F-CDC9A0FB00E1 Q33614135-C400D8E5-7B2D-47BA-A7DF-ACBC40DE3002 Q33720141-D22F221B-D48A-4E80-BA96-AEF975B31741 Q33852943-E5B90647-D97D-4ED7-A67F-5F59BEDC9899 Q34120490-F1B6F833-42C8-406F-B72E-F382C9EE9F13 Q34121775-B1E8EB2F-2478-4194-8D0F-02E915571AD0 Q34268690-CEE2CCE9-33FE-41A2-A13C-2FEAC664D958 Q34297010-77014539-5584-4FDB-93FE-C4A0B803E8D1 Q34455971-7ED61325-A1C4-426E-BC63-7E6F6A2CDC91 Q34457775-664155A3-28EB-41C6-8795-AAFC305ACAA6 Q34458416-F513B7FF-1842-4555-9855-C7BE00280EB4 Q34499610-5C4AB08B-92A8-4AAB-AC35-E34F633FFE2B Q34684953-5A9BD5CC-4B21-48DD-BD2E-F13D1521D940 Q34918663-1A75DA7C-43C3-4F9A-95A5-5C0523AF43C1 Q35022012-F554CEB5-C1C5-4B4F-BFBB-C24C38AD0CEA Q35085312-A86F338C-7599-4828-9BE8-2F50AA733B18 Q35133287-6A9F0D5D-E411-4893-8CAC-7F25F497E9F8 Q35286322-84235E05-814A-44C8-99C7-CABF2F0B4EBF Q35286339-05420CDD-DA28-47A5-920F-81DFD6023234 Q35661834-FD162AF5-8D79-4972-861C-F2197BA90897 Q35881667-BD11CAC2-47D0-4385-8487-117286F1E335 Q36274955-F58A0D12-3065-47E3-936A-CE0FEE47833C Q36275423-4CA0C015-9EB3-4877-9075-06533B23086C Q36371672-D3B2084F-6399-413E-AF28-AF99319B87AB Q36888926-5A2C1FF4-9004-40EC-B8E6-53BCC0AB3C65 Q37092936-14A8B235-C67B-4B6D-91E6-D7F77FDADCCC Q37570347-91DD410E-00A2-4B48-855C-C6A9702C6BFD Q37585406-C91A168A-19C2-42BE-9F7D-EF84032C531E Q37642476-B421EE88-FB86-40C7-871D-C0F96C43239F Q37733638-45DB3EBD-C4B9-42D6-81F2-E4049104058D Q37738596-C10650E8-C76F-4E18-8485-8B1FA933D07A

P2860

Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.

http://www.wikidata.org/entity/Q38075417

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Translating cardioprotection f ...... uropean Society of Cardiology.

@en

type

label

Translating cardioprotection f ...... uropean Society of Cardiology.

@en

prefLabel

Translating cardioprotection f ...... uropean Society of Cardiology.

@en

P1433

Q38075417-270FF4E1-DA78-4D8E-9828-3B7F75797F1E

P1476

Q38075417-A958EE5B-79B4-4FA3-8E86-0B470BAC8F74

P2093

Q38075417-42AC5062-671D-4CBA-BF17-725E71FBAEEA

Q38075417-48B4317D-3102-4B8B-8551-E211B87F0248

Q38075417-4D53892C-9638-4038-9420-BFFA0FE929A1

Q38075417-552B6692-7DB0-4153-A79E-D950EC9F5ADD

Q38075417-65025B6C-1B4A-4441-AD04-A97F4B02DF3D

Q38075417-AC04B9D6-454B-452F-87B9-52DFB7AD404A

Q38075417-D87968DE-3122-47C7-AE2F-302FC2B2C14A

Q38075417-E966FD62-DBDB-4FBD-B027-EB91336072AB

P2860

Q38075417-0062B75D-E573-4F1E-8852-AEC40C455780

Q38075417-00C4E08E-CEDA-4E63-BE2F-6AE37756166D

Q38075417-01D9C925-E408-4212-BC30-C4813B1276F7

Q38075417-03736992-F06B-4572-BDD7-20ADB826389C

Q38075417-03B43DB3-938A-412E-9EA9-A640F6CFE867

Q38075417-03D774A4-D5A5-4FCD-87BC-68F81781D251

Q38075417-04B643F6-E82F-4FF8-9AB5-BCC83662707F

Q38075417-05E68130-E931-42E1-ADE3-15D67AF77A27

Q38075417-066173BE-A3B9-4ED8-ACE0-518A5FCF06BD

Q38075417-066A2DB3-8151-4407-9F35-20322B01FEBB

P304

Q38075417-17B89286-53F3-48B5-B32D-B48C066BE50F

P31

Q38075417-18FD1544-C7EA-4C43-97F5-C65DD5F8B960

P356

Q38075417-40C95571-CFC3-4D08-BE84-0C34B794B25E

P433

Q38075417-CE75AC06-F6BE-4139-AF1D-84CE6803EB1F

P478

Q38075417-290444F8-6D04-4777-A6D5-F680ADDB8BB6

P50

Q38075417-8DB0A21C-1812-493B-A3B6-02CD25274835

Q38075417-9968AEB8-6AFC-4B4D-A4B9-5F9A8DA19049

Q38075417-9A11355A-94DC-4026-B4BB-08ACE59236D7

Q38075417-9A338A0F-11BE-407B-BE4D-CAFAEFEC9688

Q38075417-B660F6E9-4983-4747-B395-D663BC7837D5

Q38075417-DD7EE5B7-8600-4160-8AC6-0A5F8F406C7D

P577

Q38075417-60BC6416-2FE6-41F2-AA5C-7D57A657F882

P5875

Q38075417-DA720503-698A-4EC6-BC33-05987E0612F5

P698

Q38075417-8A8520CF-BD06-4D39-AC79-5C39BA4D3C27

P921

Q38075417-CCE0DD36-2A93-4A24-B1C4-95CBA2006634

P356

P1433

Cardiovascular Research

P1476

Translating cardioprotection f ...... European Society of Cardiology

@en

P2093

David Garcia-Dorado

http://www.w3.org/2001/XMLSchema#string

Gerd Heusch

http://www.w3.org/2001/XMLSchema#string

Hans Erik Bøtker

http://www.w3.org/2001/XMLSchema#string

Linda W van Laake

http://www.w3.org/2001/XMLSchema#string

Marisol Ruiz-Meana

http://www.w3.org/2001/XMLSchema#string

Michel Ovize

http://www.w3.org/2001/XMLSchema#string

Peter Ferdinandy

http://www.w3.org/2001/XMLSchema#string

Sandrine Lecour

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)

Calcium-mediated cell death during myocardial reperfusion

Cardioprotection during cardiac surgery

Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning

Low-pressure reperfusion alters mitochondrial permeability transition

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial.

Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries.

Determination of the myocardial area at risk with pre- versus post-reperfusion imaging techniques in the pig model.

Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial.

P304

7-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CVR/CVT004

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P50

Gianluigi Condorelli

Derek J Hausenloy

Rosalinda Madonna

P577

2013-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234701512

http://www.w3.org/2001/XMLSchema#string

P698

23334258

http://www.w3.org/2001/XMLSchema#string

P921